These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 31383654)
1. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China. Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654 [TBL] [Abstract][Full Text] [Related]
2. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Lee JY; Ko KS Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662 [TBL] [Abstract][Full Text] [Related]
3. Resistance and Heteroresistance to Colistin in Liao W; Lin J; Jia H; Zhou C; Zhang Y; Lin Y; Ye J; Cao J; Zhou T Infect Drug Resist; 2020; 13():3551-3561. PubMed ID: 33116674 [TBL] [Abstract][Full Text] [Related]
4. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China. Hu H; Shi Q; Zhang P; Quan J; Han X; Zhao D; Zhang H; Wang Q; Jiang Y; Yu Y Int J Antimicrob Agents; 2023 Aug; 62(2):106873. PubMed ID: 37276893 [TBL] [Abstract][Full Text] [Related]
6. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China. Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526 [TBL] [Abstract][Full Text] [Related]
7. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea. Lee JY; Song JH; Ko KS Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals. Jafari-Ramedani S; Nazari M; Arzanlou M; Peeri-Dogaheh H; Sahebkar A; Khademi F BMC Microbiol; 2024 May; 24(1):152. PubMed ID: 38702660 [TBL] [Abstract][Full Text] [Related]
9. Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa. Lo Sciuto A; Imperi F Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263076 [TBL] [Abstract][Full Text] [Related]
10. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients. Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359 [TBL] [Abstract][Full Text] [Related]
11. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin. Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794 [TBL] [Abstract][Full Text] [Related]
12. R Kuang Q; He D; Sun H; Hu H; Li F; Li W; Hu G; Wu H; Yuan L Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868331 [TBL] [Abstract][Full Text] [Related]
13. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients. Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224 [TBL] [Abstract][Full Text] [Related]
14. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa. Ly NS; Yang J; Bulitta JB; Tsuji BT Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116 [TBL] [Abstract][Full Text] [Related]
15. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434 [TBL] [Abstract][Full Text] [Related]
17. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB. Chung ES; Lee JY; Rhee JY; Ko KS J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641 [TBL] [Abstract][Full Text] [Related]
18. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Barrow K; Kwon DH Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance. Banerjee T; Adwityama A; Sharma S; Mishra K; Prusti P; Maitra U Indian J Med Microbiol; 2024; 47():100494. PubMed ID: 37890411 [TBL] [Abstract][Full Text] [Related]